We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$71.6B
AUM Growth
+$8.36B
Cap. Flow
+$5.19B
Cap. Flow %
7.25%
Top 10 Hldgs %
7.9%
Holding
3,652
New
433
Increased
1,585
Reduced
1,146
Closed
462

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$468M
2
JNJ icon
Johnson & Johnson
JNJ
+$440M
3
IBM icon
IBM
IBM
+$355M
4
BKNG icon
Booking.com
BKNG
+$332M
5
RAI
Reynolds American Inc
RAI
+$331M

Sector Composition

Rank Sector Weight
1 Healthcare 15.02%
2 Technology 13.31%
3 Financials 12.25%
4 Industrials 9.65%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELTK icon
3101
Eltek
ELTK
$57.7M
$80K ﹤0.01%
22,140
+260
+1% +$1.05K
AACG
3102
ATA Creativity
AACG
$41.9M
$78K ﹤0.01%
20,599
+99
+0.5% +$355
NSYS icon
3103
Nortech Systems
NSYS
$40.4M
$78K ﹤0.01%
21,300
-2,000
-9% -$7.9K
ORKA
3104
Oruka Therapeutics
ORKA
$5.46B
$78K ﹤0.01%
142
+53
+60% +$29.6K
AXAS
3105
DELISTED
Abraxas Petroleum Corp
AXAS
$78K ﹤0.01%
1,919
-17,937
-90% -$819K
VNCE icon
3106
Vince Holding Corp
VNCE
$77.6M
$77K ﹤0.01%
+4,960
New +$119K
EDUC icon
3107
Educational Development Corp
EDUC
$12.2M
$76K ﹤0.01%
22,662
-16,800
-43% -$73.6K
NURO
3108
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$76K ﹤0.01%
191
+45
+31% +$19.4K
NOTV
3109
DELISTED
Inotiv
NOTV
$75K ﹤0.01%
53,700
+32,200
+150% +$36.6K
OXBR icon
3110
Oxbridge Re Holdings
OXBR
$11.8M
$75K ﹤0.01%
+11,400
New +$70.3K
HTGM
3111
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$75K ﹤0.01%
61
-262
-81% -$126K
ESEA icon
3112
Euroseas
ESEA
$538M
$74K ﹤0.01%
7,892
-22,629
-74% -$234K
CASC
3113
DELISTED
Cascadian Therapeutics, Inc.
CASC
$74K ﹤0.01%
+17,988
New +$75.6K
NTZ
3114
Natuzzi
NTZ
$15.3M
$73K ﹤0.01%
5,080
-1,480
-23% -$17.8K
XTIA icon
3115
XTI Aerospace
XTIA
$57.3M
0
AIM
3116
AIM ImmunoTech
AIM
$6.54M
$73K ﹤0.01%
30
-2
-6% -$5.11K
USAS
3117
Americas Gold and Silver
USAS
$1.31B
$71K ﹤0.01%
+9,750
New +$76.6K
SDT
3118
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$70K ﹤0.01%
49,956
-35,687
-42% -$54K
MUX icon
3119
McEwen Inc
MUX
$1.03B
$69K ﹤0.01%
2,250
-16,310
-88% -$588K
ZNB
3120
Zeta Network Group
ZNB
$679K
0
INDP icon
3121
Indaptus Therapeutics
INDP
$231M
$66K ﹤0.01%
6
+1
+20% +$11.1K
YHGJ icon
3122
Yunhong Green CTI Ltd
YHGJ
$7.38M
$66K ﹤0.01%
1,160
+80
+7% +$4.72K
PSTV icon
3123
Plus Therapeutics
PSTV
$25.9M
0
EMXX
3124
DELISTED
Eurasian Minerals Inc
EMXX
$64K ﹤0.01%
68,511
-20,389
-23% -$19K
ASM
3125
Avino Silver & Gold Mines
ASM
$964M
$62K ﹤0.01%
35,700
-20,100
-36% -$34.7K

Similar funds

Renaissance Technologies's Q1 2017 Portfolio in Review

As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.

  • Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
  • Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
  • Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
  • Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
  • Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
  • Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
  • Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.